Checkpoint Therapeutics, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)

6 Months Ended

Jun. 30, 2019

Summary of restricted stock award activity

The following table summarizes restricted stock award activity for the six months ended June 30, 2019:


		Weighted Average
		Grant Date Fair
	Number of Units	Value
Nonvested at December 31, 2018	2,932,106	$	4.22
Granted	781,652		3.35
Forfeited	(21,000)		3.16
Vested	(180,626)		1.06
Nonvested at June 30, 2019	3,512,132	$	4.34

Summary of stock option award activity

The following table summarizes stock option award activity for the six months ended June 30, 2019:


				Weighted Average
				Remaining
		Weighted Average		Contractual Life
	Stock Options	Exercise Price		(in years)
Outstanding as of December 31, 2018	60,000	$	5.43	8.09
Granted	50,000		3.25	9.57
Outstanding as of June 30, 2019	110,000	$	4.44	8.49

Summary of warrant activities

A summary of warrant activities for the six months ended June 30, 2019 is presented below:


				Weighted Average
				Remaining
		Weighted Average		Contractual Life
	Warrants	Exercise Price		(in years)
Outstanding as of December 31, 2018	4,280,972	$	6.69	2.33
Exercised	(47,379)		—	—
Outstanding as of June 30, 2019	4,233,593	$	6.77	1.78

Summary of stock-based compensation expense

The following table summarizes stock-based compensation expense for the three and six months ended June 30, 2019 and 2018 ($ in thousands):


	For the three months ended June 30,				For the six months ended June 30,
	2019		2018		2019		2018
Research and development	$	184	$	(392)	$	380	$	288
General and administrative		629		464		1,231		921
Total stock-based compensation expense	$	813	$	72	$	1,611	$	1,209

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References + Details